Wednesday 29 November 2017

Global Vision Care Market Overview 2017, Demand by Regions, Share and Forecast 2017 to 2022

The global vision care market has witnessed a moderate growth over the past few years. Some of the major driving factors include growing geriatric population, sedentary lifestyle, constant exposure to electronic screens and increasing cases of eye disorders.


IMARC Group’s latest report, titled “Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global vision care market reached a value of US$ 54 Billion in 2016. Eyes are organs which provide vision to human beings so as to process visual details. Vision is vital for performing daily activities such as reading, watching, writing, playing, etc. Changing lifestyles, increasing pollution, unhealthy eating habits, etc. have resulted in a gradual rise in the number of eye complications such as conjunctivitis, myopia, diabetic retinopathy, astigmatism, macular edema, hyperopia, retinal tears and optic neuritis. This has resulted in the development of vision care products and treatments, over the past few years.

Highlights of the global vision care market:
  • Increasing incidences of eye problems and sedentary lifestyle are the major drivers of the vision care market.
  • On the basis of product type, glass lenses account for the majority of the market share.
  • North America holds for the majority of the global share, representing the largest market.
Expanding geriatric population and a surge in the cases of eye disorders and diseases worldwide are the primary growth-inducing factors for the market. Around 285 million people across the globe are visually impaired, out of which 246 million have low vision as a result of unhealthy diet and lifestyle dominated by constant use of electronic devices such as mobiles, laptops, tablets, computers, etc. Owing to these factors, an upsurge has been witnessed in the growth of the market. Beside this, exposure to airborne dust and other contaminants also affect the vision, thereby, contributing to the growth aspects of the vision care market. Moreover, rising brand consciousness among the consumers coupled with surging income levels have led them to opt for better quality products. According to the report, the market is further expected to reach a value of US$ 66 Billion by 2022, exhibiting a CAGR of more than 3% during 2017-2022.

The market has been segmented on the basis of type, wherein glass lenses account for the majority of the global market share. They are followed by contact lenses, intraocular lenses, contact solutions, lasik equipment and artificial tear. The market is further segregated on the basis of distribution channels into retail stores, online stores, clinics and hospitals. Amongst these, retail stores hold the majority of the total sales. Region-wise, North America represents the leading market, followed by Europe, Asia Pacific, Latin America, and Middle East and Africa. On analysing the competitive landscape of the market, it is found that Johnson & Johnson, Cooper, Valeant Pharmaceuticals, Essilor, and Novartis AG are the key players.


The report has examined the global vision care market on the basis of:

Product Type:
  • Glass Lenses
  • Contact Lenses
  • Intraocular Lenses
  • Contact Solutions
  • Lasik Equipment
  • Artificial Tear
Distribution Channel:
  • Retail Stores
  • Online Stores
  • Clinics
  • Hospitals
Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Major Manufacturers:
  • Johnson & Johnson
  • Cooper
  • Valeant Pharmaceuticals
  • Essilor
  • Novartis AG
Browse related reports:



About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Follow us on twitter: @imarcglobal

Monday 27 November 2017

Global Artificial Organs Market Overview 2017, Demand by Regions, Share and Forecast to 2022

The global artificial organs market has been witnessing a healthy growth. This can be attributed to ageing population, rising number of road accidents, scarcity of organ donors, advancements in the technology, etc.

Request sample report @ http://www.imarcgroup.com/request?type=report&id=833&flag=B

The latest report by IMARC Group, titled “Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global artificial organs market reached a value of more than US$ 12 Billion in 2016. Artificial organs are man-made electrical devices that are integrated into a human body so as to replace a damaged or missing natural organ. They are composed of plastic that is seeded with stem cells from the transplant recipient, due to which the body’s immune system does not reject the artificial organ. These bio-artificial devices can temporarily or permanently substitute organs and provide support for restoring a specific function so that the patient can heal rapidly. Artificial organs include pacemaker, artificial heart and artificial substitutes for missing limbs or performing kidney functions.

Highlights of the global artificial organs market:

  • Ageing population and growing cases of chronic diseases are major growth driving factors.
  • Artificial kidney represents the most popular product type, leading the artificial organs market.
  • North America represents the largest market, holding the majority of the global share.

A rise in geriatric population, growing prevalence of chronic diseases and a surge in the number of people suffering from organ failures and limb amputation are the major growth-inducing factors for the artificial organs market. Further, unavailability of organ donors at the time of requirement coupled with growing public awareness about the advancements in the healthcare sector are contributing to the growth of the market. As a result of rising incidences of road accidents and injuries leading to amputations, the demand for artificial organs has further increased. Furthermore, advancements in technological innovations to develop affordable artificial organs are also projected to aid the market growth. According to the report, the market is expected to reach a value of more than US$ 20 Billion by 2022, exhibiting a CAGR of nearly 7% during 2017-2022.

On the basis of key applications, artificial kidney represents the largest product type. Other major product types include artificial heart, cochlear implants and artificial pancreas. On the basis of region, North America represents the largest market for artificial organs, accounting for the majority of the total global share. Other major regions include Europe, Asia-Pacific, Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that the key players include Abiomed, Inc., Heartware International, Inc., Edwards Lifesciences Corp, Boston Scientific Corporation and Cochlear Limited.

Read full report with TOC @ http://www.imarcgroup.com/artificial-organs-market

The report by IMARC Group has examined the global artificial organs market on the basis of:

Type:

  • Artificial Kidney
  • Artificial Heart
  • Artificial Pancreas
  • Cochlear Implants
  • Others

Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Major manufacturers:

  • Abiomed, Inc.
  • Heartware International, Inc.
  • Edwards Lifesciences Corp
  • Boston Scientific Corporation
  • Cochlear Limited

Browse related reports:

Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com

Follow us on twitter: @imarcglobal

Monday 20 November 2017

Global Breast Pump Market Overview 2017: Growth, Demand and Forecast Research Report to 2022

The global breast pump market has witnessed a positive growth over the past several years. This can be accredited to growing number of working women, inflating disposable incomes, technological advancements and growing acceptance of breast pumps across the world.

Request sample report: http://www.imarcgroup.com/request?type=report&id=855&flag=B

According to IMARC Group’s latest report, titled “Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global breast pump market reached a value of US$ 642 Million in 2016. Breast pump is a mechanical device that extracts milk from the breasts of a lactating woman by using suction which triggers the milk ejection. The application of breast pump prevents discomfort and the expressed milk can be used to feed to the baby later, as per the need. This device is highly useful for women who are not able to nurse their babies constantly. Additionally, a breast pump can also be used to stimulate lactation for women with a low milk supply. Breast pumps include manual devices driven by hand or foot movement, or electrical devices powered by batteries.

Highlights of the global breast pump market:

  • Growing number of working women has fueled the global breast pump market.
  • Battery-powered breast pump accounts for the majority of the market share.
  • North America represents the leading market.

The global breast pump market is driven by growing women employment rate. A majority of working women resume work immediately after giving birth, resulting in busy schedules and hectic lifestyles. In order to meet the basic requirements of babies, more and more women are adopting breast pumps to store and provide breastmilk as and when needed. Moreover, growing awareness about the benefits of breast milk and importance of breastfeeding has stimulated the demand for breast pumps globally. Additionally, technological advancements have encouraged the manufacturers to come up with advanced products, such as double breast pumps, which has widened the consumer base. Some of the other factors driving the growth of the global breast pump market are government initiatives towards consumer awareness and improving healthcare infrastructure, especially in the emerging economies. Owing to the abovementioned factors, the market is expected to reach a value of US$ 972 Million in 2022, exhibiting a CAGR of around 7% during 2017-2022.

The global breast pump market is segmented on the basis of type, including closed system breast pump and open system breast pump. On the basis of technology, battery-powered breast pump account for the majority of the market share, followed by electric breast pump and manual breast pump. The market is also segmented on the basis of application, into hospital and personal care. Region-wise, North America represents the largest market, accounting for the majority of the total share. North America is followed by Europe, Asia-Pacific, Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that Philips Avent, Pigeon Corporation, Medela, Ameda and Hygeia Medical Group II are the key global players.

Read full report with TOC: http://www.imarcgroup.com/breast-pump-market

The report by IMARC Group has examined the global breast pump market on the basis of:

Type:

  • Closed System Breast Pump
  • Open System Breast Pump

Technology:
  • Battery-Powered Breast Pump
  • Electric Breast Pump
  • Manual Breast Pump

Application:

  • Hospital
  • Personal Care

Regions:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Key Players:

  • Philips Avent
  • Pigeon Corporation
  • Medela
  • Ameda
  • Hygeia Medical Group II


Browse related reports:

Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Wednesday 1 November 2017

Global Generic Drugs Market Size, Share, Price Trends, Forcast 2017-2022

The global generic drugs market has witnessed a rapid growth in recent years. Some of the factors which have helped in the market growth of generic drugs are their performance characteristics, cost-effectiveness, reduced investments in R&D, patent expiry of the branded drugs, etc.

The latest report by IMARC Group titled, “Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global generic drugs market reached a value of nearly US$ 230 Billion in 2016, growing at a CAGR of more than 7% during 2010-2016. Generic drugs have the same active ingredients and possess similar performance characteristics as their branded variants, such as strength, quality, form, effect, intended use, side effects, route of administration, therapeutic effect, etc. These drugs are manufactured under the same rules and regulations of manufacturing practices required for branded drugs. However, they are sold under their chemical names rather than the brand names.




Highlights of the global generic drugs market:

  • The market is driven primarily by their affordability.
  • The USA represents the largest market for these drugs, accounting for the majority of the share.
  • The market is expected to reach a value of around US$ 360 Billion by 2022.


To get more information, please visit @ http://www.imarcgroup.com/generic-drug-manufacturing-plant

The cost-effectiveness of the generic drugs has emerged as one of the major factors which has contributed in influencing the growth of the market. These drugs require low investments in research & development, which brings down the cost of manufacturing significantly. This has encouraged the government and third-party payers to promote the manufacturing of these drugs and save billions of dollars on healthcare expenditures. Apart from this, the patent expiry of the branded drugs is also an essential factor which provides encouragement to the generic drugs market. Most branded drugs come with a lifespan of 20 years during which other manufacturers cannot sell the branded drugs under their companies’ name. However, when the patent protection expires, the manufacturing rights of these drugs is available to the other manufacturers. Some of the other growth inducing factors include rising aging-population, increasing prevalence of chronic diseases, and incentives offered to physicians and pharmacists to promote generics. Further, the market is expected to reach a value of nearly US$ 360 Billion by 2022.

The report has segmented the market on a regional basis. Some of the major markets for generic drugs include USA, China, Brazil, Germany and France. Amongst these, USA is the largest market, accounting for the majority of the share. An analysis of the competitive landscape provides the details of the key players operative in the market. Some of the major players are Teva Pharmaceuticals, Novartis–Sandoz, Mylan, Freseunis, and Hospira.

The report has examined the global generic drugs market on the basis of:

Key Regions:
  • USA
  • China
  • Brazil
  • Germany
  • France


Key Players:
  • Teva Pharmaceuticals
  • Novartis - Sandoz
  • Mylan
  • Freseunis
  • Hospira


Browse more related reports:



About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
Tel No: +1-631-791-1145
Email: sales@imarcgroup.com
Follow us on twitter: @imarcglobal